European Healthcare Investor Association (E.H.I.A.)’s Post

A great meeting is about to start for Healthcare Business Insight teams. Manuel Guzman Martin and Siegfried Ertl from #AplusA are presenting Real World based evidence of ethnicity impact on Multiple Myeloma treatment journey in the US. #AplusA #MMSynditrack #MultipleMyeloma

Looking forward to connecting with experts from >40 countries and discuss opportunities and challenges in our industry. See you in #Basel at #SwissBiotechDay!

🌍 Exciting News: I’ll be attending CPHI this year, representing both 1MED and 1LAB! As the Head of Preclinical BU at 1MED SA and R&D and BD Manager at 1LAB SA, I’m thrilled to share that this will be a great opportunity to introduce our newest venture: 1LAB. 🔬 1LAB is a research and development laboratory within the 1MED group, positioned as a strategic and consultative partner, especially for start-ups and companies in the medtech, cosmetic, and nutraceutical sectors. What sets us apart? Our operational agility and ability to offer personalized services that go beyond simple test execution. At 1LAB, we focus on problem-solving, regulatory compliance, and product certification—bringing the benefit of a deep partnership with 1MED, which ensures we understand the next steps in your journey to market success. We offer a blend of university-like innovation with a commitment to quality and efficiency, making us an ideal partner for start-ups and companies seeking tailored solutions. With my background in pharmaceutical technology and regulatory affairs, I’m confident our team can deliver a comprehensive range of services—from R&D and product development, to validation, efficacy, and safety testing, right through to regulatory support. I’d love to connect during CPHI! Let’s schedule a meeting to explore how 1LAB can support your projects and drive your success. #MedTech #CPHI #1LAB #Innovation #R&D #Pharma #Startups #1MED #Nutraceuticals

There’s only one week to go until we welcome innovators and thought leaders to the Fourth Annual Nordic Innovation Day. I’m looking forward to returning to the Lundbeck Valby Headquarters in Denmark on 26 September, where throughout the day, we will hear themes that resonate with the clinical research community in the Nordics. We’re delighted to be welcoming a host of speakers and panelists who will share their experience and advice: Johannes Streffer, Alastair Clewlow, Jonathan Palmer, Claire Biot, Daniel Jonker, Charlotte Preuss Nielsen, Ulf Hannelius , @Omar hamidi, Katja Bernstein, Louise Lind Skov, Waheed Jowiya, PhD, Nicolai Lolansen, Troels Nielsen, Fiona Maini, Kristiina Kompus and Sarah Westall There is very limited availability at the event. For the agenda and more details, visit the NID website #NIDDenmark #Medidata #Lundbeck #WeAre3DS #FerringPharmaceuticals #AscendisPharma #DiamydMedical #NovoNordisk #LifeSciences #Nordic #LifeSciences #digitaltransformation #ClinicalTrials #Medidata #artificialintelligence #AIinHealthcare #ClinicalDevelopment #Pharma #DigitalHealth #AI #productivity #PatientCentricity #datamanager #VirtualTwin #clinicalinnovation #regulatory #regulatorylandscape #regulatorychange #clinicaldatamanagement #modellingandsimulation #digitalhealth #digitalhealthtechnologies #generativeai #largelanguagemodels #medicalimaging 

An important milestone reached on our pathway towards Epidemic/Pandemic Preparedness. Looking forward to next steps to complete the entire Research Chain, from ideas to therapies in just few weeks. Yes, we can at Takis. Takis #geneticvaccines #epidemicpreparedness

The book “Il Destino in una Parola”, written by our own Erika Salvatori and Emanuele Marra, in collaboration with Labozeta SpA, tells the story of resilience and scientific excellence of our company Takis. On February 19th, we had the pleasure of sharing this journey at Regione Lazio headquarters with a diverse audience. Since our start in 2009 during the global economic crisis, Takis has always managed to turn challenges into opportunities, embracing change with speed and agility — a spirit reflected in our name's Greek origin. In the face of the 2020 pandemic, we made another pivotal decision, leveraging our DNA vaccination platform against tumors to create a Covid-19 vaccine. Today, as we confront the global challenge of pandemic preparedness, we are rapidly changing again by enhancing our capabilities with new infrastructures like a BSL3 laboratory and a GMP facility to develop vaccines and therapies against potential pathogens triggering future pandemics. Retracing the events of our 14 years journey were Gennaro Ciliberto, who also edited the preface of the book, our CEO Luigi Aurisicchio and our CSO Giuseppe Roscilli. We also extend our sincere gratitude to Giuliano Peretti, who served as moderator, and to Massimiliano Maselli and Luciano Ciocchetti, who participated in the event highlighting the significance of investing in scientific research and innovation for the prosperity of our country. We sincerely hope that our experience may serve as an inspiration for those venturing into high level research and entrepreneurship in Italy and Lazio region. #biotech #biotechnology #research #innovation #pandemic #health #pharma #pharmaceutical

Join ERGOMED Group TODAY at Outsourcing in Clinical Trials Europe 2024! 💡 Discover how Ergomed solutions can optimize your operations at Booth #80. Our Clinical Research experts, Marijana Prodan and Alba Peña Paris, along with PrimeVigilance 's Iwona Kmicikiewicz, joined by our commercial team of Bernd Saynisch and Aleksandra Marinkovic, are available to answer any queries you may have. Looking forward to continuing discussions today! #ClinicalResearch #OCTEurope2024 #Barcelona

🎵If you're going to San Francisco - You're gonna meet some innovations there🎵 At least if you go in January, as FGK Clinical Research GmbH always does. The #JPM2024 conference and the Biotech Showcase are a good opportunity to land new business and financing for the biotech sector. Edgar Fenzl and Martin Krauss experienced new optimism in the biotech industry to get increased financing during 2024. And for FGK, this was an excellent opportunity to convince these companies about the benefits of conducting their clinical trials in Europe. #wefeelresponsible #clinicaltrial #clinicalresearch #CRO

In 2023, Quindio BioTech embarked on a transformative journey, guided by three fundamental principles: 1. Dedication to Rare Diseases ↳ The commitment was unwavering, leaving no room for half-measures. ↳ Their mission: To establish a beacon of hope for rare diseases. 2. Building Stakeholder Engagement ↳ They consistently engaged government entities, pharmaceutical companies, patients, and their families. ↳ Together, they forged a collective effort to reshape healthcare in Quindío. And the most pivotal part... 3. Embracing Positive Outcomes ↳ The new branding warmly received support from universities, scientific institutions, and other key stakeholders. ↳ This branding strategy catalyzed collaboration and yielded tangible positive results. Before dismissing it as mere branding... - Quindío's government fully embraced the initiative. - Leading scientific institutions rallied behind the cause. - Tangible and meaningful outcomes started to materialize. - And this is just the beginning! It's a straightforward formula... Engage → engage more → achieve the extraordinary. Join Quindio BioTech and Jaime Henrique Berrio Trujillo on their journey to revolutionize healthcare in the region! 🏥🤝 P.S. want to see the whole project? https://lnkd.in/eKpnh83E

An exciting month ahead for the PHARMExcel team! We can’t wait to be taking part in several industry-leading events. Tomorrow, our CEO Yvanne Enever and our Head of Clinical Ops Margaret Irwin will be in Cambridge at the BioIndustry Association (BIA) #WomeninBiotech meeting, discussing the challenges female leaders face in securing investment #InvestInWomen 👀 Hot topics on the agenda include the different types of funding, how to find your potential investors, how to prepare for a fundraise process, what investors look for when reviewing your pitch deck and conducting due diligence, and questions to ask of a potential investor.  📅 The following week we’ll be joining the Advanced Therapies Congress London, where we’ll be discussing strategies for setting up ATMP clinical trials in the UK, with a particular focus on efficiency and quality outcomes. Full agenda and registration: https://lnkd.in/gBZjdrk Book in a time to meet the team info@pharmexcel-cro.com We’re looking forward to learning, inspiring and connecting! #InvestInWomen #InspireInclusion #WomeninBiotech #ClinicalTrials #CRO #Biotech